CVVT Excels at the 49th International Exhibition of Inventions in Geneva
- CVVT
- Apr 20, 2024
- 2 min read
CVVT proudly announces its outstanding success at the 49th International Exhibition of Inventions in Geneva, securing a remarkable total of 6 prestigious awards, including 3 silver medals and 3 bronze medals.

Silver Medal Awardees:
Coronaviruses Exploit a Host Cysteine-Aspartic Protease for Replication
This project sheds light on the critical role of caspase-6 in facilitating coronavirus replication and presents a promising avenue for broad-spectrum therapeutic interventions against human-pathogenic coronaviruses, as discovered by Professor Hin Chu, Professor Jasper FW Chan, Professor Kwok Yung Yuen, and Dr. Yuxin Hou.
Papain-like Protease Inhibitors for Broad-Spectrum Coronavirus Therapy
F0213, a noncovalent inhibitor identified through comprehensive screening, shows promising anti-coronaviral properties across various strains, marking a significant advancement in combating coronavirus epidemics. Developed by a collaborative team led by Professor Shuofeng Yuan and Professor Jasper FW Chan.
NanoFlu – Spray the Flu Away
NanoFlu, a groundbreaking nasal spray, is formulated with purified proteins and nucleic acids to prevent influenza transmission among humans and livestock animals. This innovative solution, developed by Professor Raven Kok and Dr Joy Yan Lam, offers a safe and effective defense against influenza spread.



Bronze Medal Awardees:
AutoLAMP: Automated Point-of-Care RT-LAMP Respiratory Virus Detection Device
AutoLAMP offers a fast, affordable, and sensitive one-tube RT-LAMP assay for respiratory virus detection, developed by Professor Kelvin KW To and team.
Broad-Spectrum Antiviral Peptide Against Multiple Respiratory VirusesThis multifunctional peptide inhibits viral entry and release effectively, showcasing broad-spectrum antiviral properties against various respiratory viruses, crafted by Dr. Hanjun Zhao and Professor Kwok Yung Yuen .
Dual-Functional Nanoparticle DIGs Against Influenza Virus and CoronavirusThis innovative nanoparticle system delivers viral defective interfering genes to combat respiratory viruses effectively, offering promising prospects in gene therapy against respiratory viruses, crafted by Dr. Hanjun Zhao , Professor Kelvin KW To, and Professor Kwok Yung Yuen .
CVVT's exceptional showing at Geneva underscores its commitment to innovative research and excellence in combating infectious diseases.